6 unchanged sentences
Management considers this transaction to be material to the Company’s consolidated financial statements and believes that the internal controls and procedures of Lima have a material effect on the Company’s internal control over financial reporting.
−Removed: We are currently in the process of incorporating the internal controls and procedures of Lima into our internal controls over financial reporting and extending our compliance program under the Sarbanes-Oxley Act of 2002 to include Lima.
−Removed: The Company will report on its assessment of the consolidated operations within the time period provided by the Exchange Act and the applicable SEC rules and regulations concerning business combinations.
+Added: During the year ended December 31, 2025, the Company has completed the process of incorporating the internal controls and procedures of Lima into our internal controls over financial reporting and extending our compliance program under the Sarbanes-Oxley Act of 2002 to include Lima.
Other than the Lima acquisition noted above, there have been no changes in our internal control over financial reporting (as defined in Rule 13a-15(f)) identified in connection with the evaluation required by Rule 13a-15(d) of the Exchange Act that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
8 unchanged sentences
Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with existing policies or procedures may deteriorate.
−Removed: Under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, our management conducted an assessment of the effectiveness of internal control over financial reporting as of December 31, 2024
−Removed: based on the criteria established in Internal Control - Integrated Framework , issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework).
+Added: Under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, our management conducted an assessment of the effectiveness of internal control over financial reporting as of December 31, 2025 based on the criteria established in Internal Control - Integrated Framework , issued by the Committee of Sponsoring
+Added: Organizations of the Treadway Commission (2013 framework).
Based on this assessment, our management has concluded that our internal control over financial reporting was effective as of December 31, 2025.
−Removed: Management’s assessment of the effectiveness of the Company’s internal control over financial reporting as of December 31, 2024 excluded Lima, which was acquired by the Company in January 2024.
−Removed: The total assets and net sales of Lima represents 21 percent and 15 percent, respectively, of the related consolidated financial statement amounts as of and for the year ended December 31, 2024.
−Removed: Companies are allowed to exclude acquisitions from their assessment of internal control over financial reporting during the year of acquisition while integrating the acquired company under guidelines established by the Securities and Exchange Commission.
Our independent registered public accounting firm is engaged to express an opinion on our internal control over financial reporting, as stated in its report, which is included in Part II, Item 8 of this Form 10-K under the caption “Report of Independent Registered Public Accounting Firm—Internal Control Over Financial Reporting.”
Other Information
−Removed: During the fiscal year ended December 31, 2024, none of our directors or officers informed us of the adoption , modification or termination of a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as those terms are defined in Regulation S-K, Item 408.
−Removed: During the fiscal year ended December 31, 2023, Matthew L.
−Removed: Trerotola, the Company’s Chief Executive Officer and Chair of the Company’s Board of Directors, terminated a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c) and originally adopted on December 8, 2022 for the sale of up to 6,000 shares of Company common stock until December 8, 2023.
+Added: During the fiscal years ended December 31, 2025 and 2024, none of our directors or officers informed us of the adoption , modification or termination of a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as those terms are defined in Regulation S-K, Item 408.
Disclosure Regarding Foreign Jurisdictions that Prevent Inspections
Directors, Executive Officers and Corporate Governance
−Removed: Information relating to our Executive Officers is set forth in Part I of this Form 10-K under the caption “Information About Our Executive Officers”.
−Removed: The following information with respect to our board of directors is presented as of February 26, 2025:
+Added: Information relating to our Executive Officers is set forth in Part I of this Form 10-K under the caption “Information About Our Executive Officers.” The following information with respect to our board of directors is presented as of February 26, 2026:
Name Age Position at Enovis Principal Employment
−Removed: Trerotola 57 Chief Executive Officer and Chair of the Board of Directors Same
−Removed: Brady Shirley 59 Director
−Removed: Kelly 58 Director Chairman, President and Chief Executive Officer of Teleflex Incorporated
+Added: Damien McDonald
+Added: 61 Chief Executive Officer and Director Same
+Added: 64 Chair of the Board of Directors
+Added: Kelly 59 Director Chairman, President and Chief Executive Officer of Teleflex Incorporated from January 2010 to January 2026
Philip Okala 57 Director Chief Operating Officer of Tufts Medicine
1 unchanged sentence
Rajiv Vinnakota 54 Director President of the Institute for Citizens & Scholars (formerly the Woodrow Wilson National Fellowship Foundation)
−Removed: Sharon Wienbar 63 Lead Independent Director Retired
Christine Ortiz 55 Director Morris Cohen Professor of Materials Science and Engineering at the Massachusetts Institute of Technology
31 unchanged sentences
Explanatory Note :
−Removed: On April 4, 2022, the Company changed its corporate name from “Colfax Corporation” to “Enovis Corporation”.
−Removed: References to “the Company” in the exhibit index below refer to “Colfax Corporation” with respect to periods prior to the date of the name change, and to Enovis Corporation with respect to periods after the date of the name change.
+Added: On April 4, 2022, the Company changed its corporate name from “Colfax Corporation” to “Enovis Corporation.” References to “the Company” in the exhibit index below refer to “Colfax Corporation” with respect to periods prior to the date of the name change, and to Enovis Corporation with respect to periods after the date of the name change.
Separation and Distribution Agreement, dated April 4, 2022, between the Company and ESAB Corporation Incorporated by reference to Exhibit 2.1 to the Company’s Form 8-K (File No.
12 unchanged sentences
Specimen Common Stock Certificate Incorporated by reference to Exhibit 4.1 to the Company’s Form S-1 (File 333-148486) as filed with the SEC on May 1, 2008
−Removed: Description of Securities registered under Section 12 of the Exchange Act Filed herewith
+Added: Description of Securities registered under Section 12 of the Exchange Act Incorporated by reference to Exhibit 4.2 to the Company’s Form 10-K (File No.
+Added: 001-34045) as filed with the SEC on February 26, 2025
Indenture, dated October 24, 2023, between the Company and U.S.
11 unchanged sentences
001-34045) as filed with the SEC on February 24, 2020
+Added: Description Location
Form of Non-Qualified Stock Option Agreement for non-officers * Incorporated by reference to Exhibit 10.6 to the Company’s Form 10-K (File No.
001-34045) as filed with the SEC on February 14, 2017
−Removed: Description Location
Form of Non-Qualified Stock Option Agreement for non-officers with retirement provision* Incorporated by reference to Exhibit 10.8 to the Company’s Form 10-K (File No.
33 unchanged sentences
001-34045) as filed with the SEC on May 27, 2020
+Added: Description Location
Form of Performance Stock Unit Agreement – Officer (w/ Retirement) (2020 Plan)* Incorporated by reference to Exhibit 10.6 to the Company’s Form 8-K (File No.
001-34045) as filed with the SEC on May 27, 2020
−Removed: Description Location
Form of Restricted Stock Unit Agreement – Chief Executive Officer (2020 Plan)* Incorporated by reference to Exhibit 10.7 to the Company’s Form 8-K (File No.
8 unchanged sentences
Form of Option Award Agreement (for awards on or after January 1, 2025) (2020 Plan)*
−Removed: Filed herewith
+Added: Incorporated by reference to Exhibit 10.27 to the Company’s Form 10-K (File No.
+Added: 001-34045) as filed with the SEC on February 26, 2025
Form of Restricted Stock Unit Agreement (for awards on or after January 1, 2025) (2020 Plan)*
−Removed: Filed herewith
+Added: Incorporated by reference to Exhibit 10.28 to the Company’s Form 10-K (File No.
+Added: 001-34045) as filed with the SEC on February 26, 2025
Form of Performance Restricted Stock Unit Agreement (for awards on or after January 1, 2025) (2020 Plan)*
−Removed: Filed herewith
+Added: Incorporated by reference to Exhibit 10.28 to the Company’s Form 10-K (File No.
+Added: 001-34045) as filed with the SEC on February 26, 2025
+Added: Form of Restricted Stock Unit Agreement (2020 Plan)* Incorporated by reference to Exhibit 10.1 to the Company’s Form 10-Q (File No.
+Added: 001-34045) as filed with the SEC on November 6, 2025
+Added: Form of Performance Restricted Stock Unit Agreement (2020 Plan)* Incorporated by reference to Exhibit 10.2 to the Company’s Form 10-Q (File No.
+Added: 001-34045) as filed with the SEC on November 6, 2025
Amended and Restated Excess Benefit Plan, effective as of January 1, 2013* Incorporated by reference to Exhibit 10.13 to the Company’s Form 10-K (File No.
20 unchanged sentences
001-34045) as filed with the SEC on July 23, 2015
+Added: Description Location
+Added: Retirement and Transition Agreement between the Company and Matthew L.
+Added: Trerotola* Incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K (File No.
+Added: 001-34045) as filed with the SEC on March 14, 2025
Employment Agreement between the Company and Daniel A.
1 unchanged sentence
001-34045) as filed with the SEC on August 7, 2012
+Added: Separation and Release Agreement between the Company and Daniel A.
+Added: Pryor, dated November 14, 2025*
+Added: Filed herewith
Letter Agreement between the Company and Phillip Benjamin Berry, dated December 31, 2022* Incorporated by reference to Exhibit 10.38 to the Company’s Form 10-K (File No.
001-34045) as filed with the SEC on March 1, 2023
+Added: Letter Agreement between the Company and Damien McDonald, dated February 27, 2025* Incorporated by reference to Exhibit 10.2 to the Company’s Form 10-Q (File No.
+Added: 001-34045) as filed with the SEC on May 9, 2025
Form of Indemnification Agreement between the Company and each of its directors and executive officers* Incorporated by reference to Exhibit 10.3 to the Company’s Form S-1 (File 333-148486) as filed with the SEC on May 1, 2008
−Removed: Description Location
Form of Change in Control Agreement* Incorporated by reference to Exhibit 10.01 to the Company’s Form 10-Q (File No.
13 unchanged sentences
001-34045) as filed with the SEC on October 25, 2023
+Added: Amendment No.
+Added: 2 to Credit Agreement, dated March 28, 2024, by and among the Company, the lenders and guarantors party thereto, and JPMorgan Chase Bank, N.A., as Administrative Agent
+Added: Filed herewith
+Added: Description Location
+Added: Amendment No.
+Added: 3 to Credit Agreement, dated December 8, 2025, by and among the Company, the lenders and guarantors party thereto, and JPMorgan Chase Bank, N.A., as Administrative Agent Incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K (File No.
+Added: 001-34045) as filed with the SEC on December 10, 2025
Transition Services Agreement, dated April 4, 2022, between the Company and ESAB Corporation Incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K (File No.
10 unchanged sentences
001-34045) as filed with the SEC on March 1, 2023
+Added: Retirement and Transition Agreement and Release between the Company and Patricia Lang, dated December 10, 2025*
+Added: Filed herewith
Enovis Corporation 2023 Non-Qualified Stock Purchase Plan
6 unchanged sentences
Incorporated by reference to Exhibit 10.55 to the Company’s Form 10-K (File No.001-34045) as filed with the SEC on February 22, 2024
−Removed: Description Location
Enovis Corporation Insider Trading Policy
−Removed: Filed herewith
+Added: Incorporated by reference to Exhibit 19.1 to the Company’s Form 10-K (File No.
+Added: 001-34045) as filed with the SEC on February 26, 2025
Subsidiaries of registrant Filed herewith
21 unchanged sentences
ENOVIS CORPORATION
−Removed: /s/ MATTHEW L.
−Removed: Chair of the Board, Chief Executive Officer and Director
+Added: /s/ DAMIEN MCDONALD
+Added: Damien McDonald
+Added: Chief Executive Officer and Director
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the date indicated.
February 26, 2026
−Removed: /s/ MATTHEW L.
−Removed: Chair of the Board, Chief Executive Officer and Director
+Added: /s/ DAMIEN MCDONALD
+Added: Damien McDonald
+Added: Chief Executive Officer and Director
(Principal Executive Officer)
6 unchanged sentences
(Principal Accounting Officer)
+Added: /s/ SHARON L.
+Added: Chair of the Board
CHRISTINE ORTIZ
7 unchanged sentences
Rajiv Vinnakota
−Removed: /s/ SHARON L.
/s/ PHILIP OKALA
17 unchanged sentences
(1) Amounts charged to expense are net of recoveries for the respective period.
−Removed: (2) Represent fair value adjustments related to acquisitions, as well as amounts charged to Goodwill and reclassifications to deferred tax asset accounts.
+Added: (2) Represents amounts charged to Accumulated other comprehensive income (loss) for the Company’s cross-currency swap agreements designated as net investment hedges in 2025 and fair value adjustments related to acquisitions charged to Goodwill in 2024.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.